Form 15-12G - Securities registration termination [Section 12(g)]
16 5월 2024 - 3:58AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSIONx
OF
DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934.
Commission
File Number 000-56140
NP
Life Sciences Health Industry Group Inc.
(Exact
name of registrant as specified in its charter)
4125
Blackhawk Plaza Circle, Suite 166
Danville,
CA 94506
(925)
362-3169
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common
stock, $0.0001 par value
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule
12g-4(a)(1) |
☐ |
|
Rule
12g-4(a)(2) |
☐ |
|
Rule
12h-3(b)(1)(i) |
☒ |
|
Rule
12h-3(b)(1)(ii) |
☐ |
|
Rule
15d-6 |
☐ |
Approximate
number of holders of record as of the certification or notice date: 59
Pursuant
to the requirements of the Securities Exchange Act of 1934, NP Life Sciences Health Industry Group Inc. has caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
Date:
May 13, 2024 |
By: |
/s/
Guidong Wang |
|
|
Guidong
Wang |
|
|
(Chief
Executive Officer) |
SEC
2069 (08-11) Potential persons who are to respond to the collection of information contained in this Form are not required to respond
unless the Form displays a currently valid OMB control number.
Instruction:
This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act
of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed
by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form
shall be typed or printed under the signature.
NP Life Sciences Health ... (PK) (USOTC:NPLS)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
NP Life Sciences Health ... (PK) (USOTC:NPLS)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024